DK0396069T3 - Salte af azelastin med forbedret opløselighed - Google Patents
Salte af azelastin med forbedret opløselighedInfo
- Publication number
- DK0396069T3 DK0396069T3 DK90108172.9T DK90108172T DK0396069T3 DK 0396069 T3 DK0396069 T3 DK 0396069T3 DK 90108172 T DK90108172 T DK 90108172T DK 0396069 T3 DK0396069 T3 DK 0396069T3
- Authority
- DK
- Denmark
- Prior art keywords
- azelastine
- salts
- improved solubility
- acid
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3914859 | 1989-05-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0396069T3 true DK0396069T3 (da) | 1994-07-25 |
Family
ID=6380164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK90108172.9T DK0396069T3 (da) | 1989-05-05 | 1990-04-28 | Salte af azelastin med forbedret opløselighed |
Country Status (17)
| Country | Link |
|---|---|
| US (4) | US5086050A (da) |
| EP (1) | EP0396069B1 (da) |
| JP (1) | JPH02295987A (da) |
| AT (1) | ATE107643T1 (da) |
| AU (1) | AU622022B2 (da) |
| CA (1) | CA2016089C (da) |
| DD (1) | DD294254A5 (da) |
| DE (2) | DE4013696A1 (da) |
| DK (1) | DK0396069T3 (da) |
| ES (1) | ES2055216T3 (da) |
| FI (1) | FI902244A0 (da) |
| HU (1) | HU206110B (da) |
| IE (1) | IE63662B1 (da) |
| NO (1) | NO901985L (da) |
| NZ (1) | NZ233546A (da) |
| PT (1) | PT93946B (da) |
| YU (1) | YU86390A (da) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5271946A (en) * | 1988-04-20 | 1993-12-21 | Asta Pharma Aktiengesellschaft | Controlled release azelastine-containing pharmaceutical compositions |
| JPH04198180A (ja) * | 1990-11-28 | 1992-07-17 | Eezai Kagaku Kk | ベンジルフタラゾン誘導体の製造方法 |
| US5296472A (en) * | 1991-12-05 | 1994-03-22 | Vyrex Corporation | Methods for delipidation of skin and cerumen removal |
| JP4138910B2 (ja) | 1997-07-02 | 2008-08-27 | 帝國製薬株式会社 | 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤 |
| CA2306875C (en) * | 1997-10-24 | 2011-01-04 | John P. Blass | Nutritional supplement for cerebral metabolic insufficiencies |
| FI982733A (fi) | 1998-12-17 | 2000-06-18 | Orion Yhtymae Oyj | Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia |
| FI109332B (fi) | 1998-12-17 | 2002-07-15 | Orion Yhtymae Oyj | Toremifeenin liukoisia koostumuksia |
| GB2389530B (en) * | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| US7694694B2 (en) * | 2004-05-10 | 2010-04-13 | The Aerospace Corporation | Phase-change valve apparatuses |
| US20070020330A1 (en) | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
| US8758816B2 (en) * | 2004-11-24 | 2014-06-24 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
| SI2377557T1 (sl) | 2004-11-24 | 2017-02-28 | Meda Pharmaceuticals Inc. | Sestavki, ki obsegajo azelastin, in postopki njihove uporabe |
| DK2697662T3 (da) | 2011-04-13 | 2018-07-30 | Codexis Inc | Biokatalytisk fremgangsmåde til fremstilling af eslicarbazepin og analoger deraf |
| US11389458B2 (en) | 2019-04-12 | 2022-07-19 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treating parkinson's and huntington's disease |
| US10639314B1 (en) | 2019-04-30 | 2020-05-05 | LA PharmaTech Inc. | Method of treating Alzheimer's disease |
| US11318144B2 (en) | 2019-04-12 | 2022-05-03 | LA PharmaTech Inc. | Compositions and methods for treating Alzheimer's disease and Parkinson's disease |
| US10966989B2 (en) | 2019-04-12 | 2021-04-06 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treating mental, behavioral, cognitive disorders |
| US10898493B2 (en) | 2019-04-12 | 2021-01-26 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for psychiatric symptoms of patients with Alzheimer's disease |
| US11690849B2 (en) | 2019-04-12 | 2023-07-04 | LA PharmaTech Inc. | Method of treating dementia |
| US11938139B2 (en) | 2019-04-12 | 2024-03-26 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for anxiety, depression and other psychiatric disorders |
| US11744833B2 (en) | 2019-04-12 | 2023-09-05 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treatment of insomnia |
| US11351179B1 (en) | 2021-08-05 | 2022-06-07 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treatment of psychiatric disorders |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH572914A5 (da) * | 1971-01-22 | 1976-02-27 | Asta Werke Ag Chem Fab | |
| US3813384A (en) * | 1972-01-17 | 1974-05-28 | Asta Werke Ag Chem Fab | Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof |
| DE3575135D1 (de) * | 1984-09-14 | 1990-02-08 | Asta Pharma Ag | Substituierte benzylphthalazinon-derivate. |
| ATE60598T1 (de) * | 1985-11-11 | 1991-02-15 | Asta Pharma Ag | 4-benzyl-1-(2h)-phthalazinon-derivate. |
| JPH0667844B2 (ja) * | 1987-03-06 | 1994-08-31 | エーザイ株式会社 | 虚血性心疾患の治療・予防剤 |
| EP0289939A1 (de) * | 1987-05-08 | 1988-11-09 | ASTA Pharma AG | Neue 4-Benzyl-1-(2H)-phthalazinon-Derivate mit einem Aminosäurerest |
| US5232919A (en) * | 1987-11-13 | 1993-08-03 | Asta Pharma Aktiengesellschaft | Azelastine embonate and compositions which contain it |
| PT88984B (pt) * | 1987-11-13 | 1993-01-29 | Asta Medica Ag | Processo para a preparação de embonato de azelastina e de composições earmacâutxcas que 0 contêm como ingrediente activo |
| ES2053679T3 (es) * | 1987-11-13 | 1994-08-01 | Asta Medica Ag | Embonato de azelastina, procedimiento para su preparacion y preparados farmaceuticos que contienen embonato de azelastina como principio activo. |
| JP2794021B2 (ja) * | 1988-11-02 | 1998-09-03 | エーザイ株式会社 | アゼラスチン或いはその塩類含有経皮適用製剤 |
-
1990
- 1990-04-28 DK DK90108172.9T patent/DK0396069T3/da active
- 1990-04-28 DE DE4013696A patent/DE4013696A1/de not_active Withdrawn
- 1990-04-28 DE DE59006184T patent/DE59006184D1/de not_active Expired - Lifetime
- 1990-04-28 AT AT90108172T patent/ATE107643T1/de not_active IP Right Cessation
- 1990-04-28 EP EP90108172A patent/EP0396069B1/de not_active Expired - Lifetime
- 1990-04-28 ES ES90108172T patent/ES2055216T3/es not_active Expired - Lifetime
- 1990-05-03 NZ NZ233546A patent/NZ233546A/xx unknown
- 1990-05-03 PT PT93946A patent/PT93946B/pt not_active IP Right Cessation
- 1990-05-04 NO NO90901985A patent/NO901985L/no unknown
- 1990-05-04 IE IE163990A patent/IE63662B1/en not_active IP Right Cessation
- 1990-05-04 DD DD90340395A patent/DD294254A5/de not_active IP Right Cessation
- 1990-05-04 CA CA002016089A patent/CA2016089C/en not_active Expired - Lifetime
- 1990-05-04 HU HU902678A patent/HU206110B/hu unknown
- 1990-05-04 FI FI902244A patent/FI902244A0/fi not_active IP Right Cessation
- 1990-05-04 AU AU54736/90A patent/AU622022B2/en not_active Ceased
- 1990-05-04 YU YU00863/90A patent/YU86390A/xx unknown
- 1990-05-07 JP JP2115947A patent/JPH02295987A/ja active Pending
-
1991
- 1991-02-08 US US07/652,986 patent/US5086050A/en not_active Expired - Lifetime
-
1996
- 1996-08-02 US US08/691,415 patent/US5859003A/en not_active Expired - Lifetime
-
1998
- 1998-07-28 US US09/123,431 patent/US5998403A/en not_active Expired - Fee Related
- 1998-08-20 US US09/136,971 patent/US6017909A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0396069B1 (de) | 1994-06-22 |
| US5086050A (en) | 1992-02-04 |
| JPH02295987A (ja) | 1990-12-06 |
| AU5473690A (en) | 1990-11-08 |
| ES2055216T3 (es) | 1994-08-16 |
| ATE107643T1 (de) | 1994-07-15 |
| US5859003A (en) | 1999-01-12 |
| US5998403A (en) | 1999-12-07 |
| EP0396069A1 (de) | 1990-11-07 |
| HU206110B (en) | 1992-08-28 |
| US6017909A (en) | 2000-01-25 |
| PT93946B (pt) | 1996-11-29 |
| CA2016089A1 (en) | 1990-11-05 |
| IE901639L (en) | 1990-11-05 |
| HU902678D0 (en) | 1990-09-28 |
| YU86390A (en) | 1992-05-28 |
| FI902244A0 (fi) | 1990-05-04 |
| CA2016089C (en) | 1998-12-01 |
| AU622022B2 (en) | 1992-03-26 |
| HUT53901A (en) | 1990-12-28 |
| DE4013696A1 (de) | 1990-11-08 |
| NZ233546A (en) | 1991-09-25 |
| DD294254A5 (de) | 1991-09-26 |
| NO901985D0 (no) | 1990-05-04 |
| IE63662B1 (en) | 1995-05-31 |
| DE59006184D1 (de) | 1994-07-28 |
| PT93946A (pt) | 1991-01-08 |
| NO901985L (no) | 1990-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0396069T3 (da) | Salte af azelastin med forbedret opløselighed | |
| CY1105091T1 (el) | Αντικατεστημενες ενωσεις 2-αρυλοβενζαζολιου και η χρηση τους σαν παραγοντες κατα των ογκων | |
| ES8603455A1 (es) | Un metodo para preparar derivados de piperazina | |
| PT1177176E (pt) | Derivados de acidos triarilicos como ligandos de receptores ppar. | |
| PT1307455E (pt) | Inibidores de adesao celular mediada por (alfa)l (beta)2 | |
| ATE284853T1 (de) | Ureido-thiobuttersäurederivate als ppar-agonisten | |
| RO91871B (ro) | Procedeu pentru prepararea unor derivati de 1,4-dihidro-4-oxonaftiridina | |
| BR0013666A (pt) | "alfa"-hidróxi-ácidos substituìdos inibidores de caspases e o seu uso | |
| EA200000826A1 (ru) | Галоидированные производные амидиноаминокислот, применимые в качестве ингибиторов no-синтазы | |
| ES8601942A1 (es) | Un procedimiento para la preparacion de nuevos derivados de benzotiazina | |
| BR0211826A (pt) | Imidazopiridinas tricìclicas | |
| TR199700206A2 (xx) | Floralkil- ve floralkoksi ikame edilmi� heterosiklik bradikinin-antagonistleri, bunlar�n imal edilmesine mahsus usul ve bunlar�n kullan�lmalar�. | |
| TR199800543A2 (xx) | Benziloksi ikame edilen, aniliye edilmi� N-heterosiklik bile�ikler. | |
| NO20014240D0 (no) | C16-umettede FP-selektive prostaglandinanaloger | |
| EA200501379A1 (ru) | Способ получения кислотно-аддитивных солей многокислотных основных соединений | |
| ES460351A1 (es) | Procedimiento para la preparacion de 2-bromo-6 - fluor-n-2- imidazolidinilidenbenzamina. | |
| ES2152097T3 (es) | Empleo de esteres de acidos hidroxicarboxilicos como espesantes. | |
| DE60025644T8 (de) | Hemmer für das 20-hete-produzierende enzym | |
| DE60105618D1 (de) | Dihydroporphyrinderivate und ihre verwendung | |
| PT98700A (pt) | Processo para a preparacao de acidos aminometanofosfonico e de acidos aminometil-fosfinicos | |
| SE9802507D0 (sv) | Novel salts | |
| TR199902117T2 (xx) | (E)-4,6- Dikloro-3-(2-okso-1-fenilpirolidin-3-iliden metil)-1H-�ndol-2-karboksilik asidin kristalimsi hidratlanm�� sodyum tuzu. | |
| SE9903345D0 (sv) | Novel process | |
| FI851073L (fi) | Inhibitor foer dopamin- -hydroxylas. | |
| RO82486B1 (ro) | Procedeu de preparare a unor 2-aminobenzofenone substituite |